M. Kron

661 total citations
20 papers, 470 citations indexed

About

M. Kron is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, M. Kron has authored 20 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in M. Kron's work include Inflammatory Bowel Disease (5 papers), Microscopic Colitis (5 papers) and Neurogenesis and neuroplasticity mechanisms (3 papers). M. Kron is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Microscopic Colitis (5 papers) and Neurogenesis and neuroplasticity mechanisms (3 papers). M. Kron collaborates with scholars based in United States, Germany and Sweden. M. Kron's co-authors include Jack M. Parent, Helen Zhang, Eckhard Schöenau, Christian Netzer, Jessica M. Franklin, Peer Eysel, Heike Hoyer‐Kuhn, Barbara Hero, Oliver Semler and Isabel Reillo and has published in prestigious journals such as Journal of Neuroscience, Gastroenterology and Gut.

In The Last Decade

M. Kron

17 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Kron United States 9 177 165 132 131 59 20 470
Raj K. Gopal United States 11 196 1.1× 352 2.1× 47 0.4× 360 2.7× 36 0.6× 15 829
Xing Zhou China 6 162 0.9× 141 0.9× 33 0.3× 238 1.8× 43 0.7× 6 459
Davinna L. Ligons United States 12 64 0.4× 190 1.2× 54 0.4× 189 1.4× 14 0.2× 20 712
Hai Jin China 11 82 0.5× 155 0.9× 79 0.6× 134 1.0× 46 0.8× 34 505
Antonio Berretta United Kingdom 11 45 0.3× 158 1.0× 68 0.5× 156 1.2× 122 2.1× 15 486
S. Komoly Hungary 13 107 0.6× 163 1.0× 17 0.1× 153 1.2× 74 1.3× 35 648
Yung‐Chih Cheng United States 9 75 0.4× 181 1.1× 23 0.2× 250 1.9× 64 1.1× 13 567
Kazuyo Ikeda Japan 12 97 0.5× 101 0.6× 32 0.2× 180 1.4× 55 0.9× 29 517
Shih‐Hsiu J. Wang United States 12 46 0.3× 132 0.8× 28 0.2× 133 1.0× 39 0.7× 28 477
Jonathan A. Fidler United States 14 31 0.2× 91 0.6× 108 0.8× 230 1.8× 56 0.9× 15 651

Countries citing papers authored by M. Kron

Since Specialization
Citations

This map shows the geographic impact of M. Kron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Kron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Kron more than expected).

Fields of papers citing papers by M. Kron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Kron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Kron. The network helps show where M. Kron may publish in the future.

Co-authorship network of co-authors of M. Kron

This figure shows the co-authorship network connecting the top 25 collaborators of M. Kron. A scholar is included among the top collaborators of M. Kron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Kron. M. Kron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schulman, Howard, Katarina Niward, Ebba Abate, et al.. (2019). Sedimentation rate and suPAR in relation to disease activity and mortality in patients with tuberculosis. The International Journal of Tuberculosis and Lung Disease. 23(11). 1155–1161. 5 indexed citations
2.
Hoyer‐Kuhn, Heike, Jessica M. Franklin, M. Kron, et al.. (2016). Safety and efficacy of denosumab in children with osteogenesis imperfect--a first prospective trial.. PubMed. 16(1). 24–32. 87 indexed citations
3.
Calster, Joachim Van, David K. Scales, Pablo Franco, et al.. (2015). Adalimumab in Patients with Active, Noninfectious Uveitis Using High-Dose Corticosteroids. UCL Discovery (University College London).
4.
Colombel, J F, William J. Sandborn, Douglas C. Wolf, et al.. (2013). PTU-055 Long-Term Efficacy of Adalimumab for Treatment of Moderately to Severely Active Ulcerative Colitis. Gut. 62(Suppl 1). A66–A67. 1 indexed citations
5.
Teixeira, Cátia M., M. Kron, Núria Masachs, et al.. (2012). Cell-Autonomous Inactivation of the Reelin Pathway Impairs Adult Neurogenesis in the Hippocampus. Journal of Neuroscience. 32(35). 12051–12065. 74 indexed citations
6.
Colombel, J F, W. Sandborn, Gert Van Assche, et al.. (2012). P213 Benefit risk assessment of adalimumab as maintenance treatment for ulcerative colitis: Near analysis of week 8 responders in ULTRA 2. Journal of Crohn s and Colitis. 6. S94–S95. 1 indexed citations
7.
Kron, M., Brenda L. Bohnsack, Steven M. Archer, Jonathan B. McHugh, & Alon Kahana. (2012). Recurrent orbital schwannomas: clinical course and histopathologic correlation. BMC Ophthalmology. 12(1). 44–44. 17 indexed citations
8.
Löfberg, Robert, Édouard Louis, Walter Reinisch, et al.. (2012). P212 Clinical outcomes in patients with moderate versus severe Crohn's disease at baseline: Analysis from CARE. Journal of Crohn s and Colitis. 6. S94–S94. 2 indexed citations
9.
Ryu, Hyunji, Elias Gounaris, M. Kron, et al.. (2011). Novel Pathway for TNF-Mediated Albumin Losses in IBD. Gastroenterology. 140(5). S–502. 1 indexed citations
10.
Kron, M., Helen Zhang, & Jack M. Parent. (2010). The Developmental Stage of Dentate Granule Cells Dictates Their Contribution to Seizure-Induced Plasticity. Journal of Neuroscience. 30(6). 2051–2059. 154 indexed citations
12.
Parent, Jack M. & M. Kron. (2010). Neurogenesis and epilepsy. Epilepsia. 51(s5). 45–45. 26 indexed citations
13.
Tang, Yueming, Daniel Clayburgh, Navdha Mittal, et al.. (2009). Epithelial NF-κB Enhances Transmucosal Fluid Movement by Altering Tight Junction Protein Composition after T Cell Activation. American Journal Of Pathology. 176(1). 158–167. 64 indexed citations
14.
Louis, Édouard, Robert Löfberg, Walter Reinisch, et al.. (2009). P118 - Adalimumab's effect on extraintestinal manifestations of Crohn's disease: results of the CARE trial. Journal of Crohn s and Colitis. 3(1). S57–S58.
15.
Reinisch, Walter, Robert Löfberg, Erik K. St. Louis, et al.. (2009). P125 - Influence of disease duration on adalimumab efficacy in Crohn's disease: subanalysis of the CARE trial. Journal of Crohn s and Colitis. 3(1). S60–S60. 2 indexed citations
16.
Rudwaleit, Martín, Pascal Claudepierre, P Wordsworth, et al.. (2008). Predictors of good clinical response (BASDAI 50 or ASAS partial remission) in 1,250 patients treated with adalimumab (humira (R)) for active ankylosing spondylitis (AS). Clinical and Experimental Rheumatology. 26(4). 744–744. 2 indexed citations
17.
Autenrieth, Michael, et al.. (2008). ARE THERE CONTRAINDICATIONS FOR A CURATIVE TREATMENT of prostate cancer patients ≥ 75 years with regard to QUALITY OF LIFE?. European Urology Supplements. 7(3). 300–300.
18.
Herkommer, Kathleen, et al.. (2007). 903 HEREDITARY VS. SPORADIC PROSTATE CANCER: DIFFERENCES IN CLINICAL DATA AND PROGRESSION-FREE SURVIVAL?. European Urology Supplements. 6(2). 248–248. 1 indexed citations
19.
Bamat, Nicolas A., et al.. (2005). Behavioral effects of toluene in rats selectively bred for infantile vocalization rate. Neurotoxicology and Teratology. 27(6). 883–890. 8 indexed citations
20.
Meden, H., Thomas Brune, M. Kron, et al.. (1997). Mib-1 evaluated proliferative activity in ovarian cancer with respect to prognostic significance.. PubMed. 17(1B). 775–80. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026